Robert Plenge, M.D., Ph.D.

Dr. Robert Plenge is a member of the Board of Directors of Beeline Medicines and the Executive Vice President and Chief Research Officer at Bristol Myers Squibb (BMS), where he leads the company’s global research organization. He also serves on the Board of Directors for Alltrna and the PhRMA Foundation. He previously served on the Board of Translate Bio. Prior to BMS, Dr. Plenge held senior research leadership positions at Celgene and Merck & Co. focused on translational medicine, genetics, and drug discovery. Earlier in his career, Dr. Plenge practiced academic medicine and conducted research in human genetics and immunology at Harvard Medical School and the Broad Institute while serving on the faculty at Brigham and Women’s Hospital. Dr. Plenge received his M.D. and Ph.D. from Case Western Reserve University and holds a B.S. from University of California San Diego.